Whereas increased activation of the complement system is reported in NAFLD (79), the specific levels of CFH mRNA were found downregulated in patients with NASH in line with protein levels of CFH in the liver (80). The gene discussed is CFH; the disease is metabolic dysfunction-associated steatotic liver disease.